📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Oncogeni

1.1 - Company Overview

Oncogeni Logo

Oncogeni

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel cell- and RNA-based cancer medicines, specializing in small interfering RNA and mesodermal killer cells.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Oncogeni

Novelos Therapeutics Logo

Novelos Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical research, development, and commercialization focused on oxidized glutathione.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Novelos Therapeutics company profile →
Blue Earth Diagnostics Logo

Blue Earth Diagnostics

HQ: United Kingdom Website
  • Description: Provider of molecular PET imaging agents and technologies for cancer diagnosis, developing and commercialising radiopharmaceuticals addressing high unmet medical needs. Offerings include Axumin (fluciclovine F 18) for detecting recurrent prostate cancer, POSLUMA (flotufolastat F 18) Injection for detecting prostate cancer, FAP-targeted PET technology for multiple solid tumors, and clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Blue Earth Diagnostics company profile →
Guided Therapeutics Logo

Guided Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Guided Therapeutics company profile →
EpiCapture Logo

EpiCapture

HQ: Ireland Website
  • Description: Provider of accurate, non-invasive urine tests to detect aggressive cancers, focused on improving cancer patient care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EpiCapture company profile →
Kolltan Logo

Kolltan

HQ: United States Website
  • Description: Provider of novel monoclonal antibody oncology therapeutics targeting receptor tyrosine kinases (RTKs); develops next-generation mAb drugs based on seminal discoveries from Dr. Joseph Schlessinger's Yale Pharmacology lab; founded in 2007 as a private company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kolltan company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Oncogeni

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Oncogeni

2.2 - Growth funds investing in similar companies to Oncogeni

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Oncogeni

4.2 - Public trading comparable groups for Oncogeni

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Oncogeni

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Oncogeni

What does Oncogeni do?

Oncogeni is a provider of novel cell- and RNA-based cancer medicines, specializing in small interfering RNA and mesodermal killer cells.

Who are Oncogeni's competitors?

Oncogeni's competitors and similar companies include Novelos Therapeutics, Blue Earth Diagnostics, Guided Therapeutics, EpiCapture, and Kolltan.

Where is Oncogeni headquartered?

Oncogeni is headquartered in United Kingdom.

How many employees does Oncogeni have?

Oncogeni has 1,000 employees 🔒.

When was Oncogeni founded?

Oncogeni was founded in 2010 🔒.

What sector and industry vertical is Oncogeni in?

Oncogeni is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Oncogeni

Who are the top strategic acquirers in Oncogeni's sector and industry

Top strategic M&A buyers and acquirers in Oncogeni's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Oncogeni?

Top strategic M&A buyers groups and sectors for Oncogeni include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Oncogeni's sector and industry vertical

Which are the top PE firms investing in Oncogeni's sector and industry vertical?

Top PE firms investing in Oncogeni's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Oncogeni's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Oncogeni's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Oncogeni's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Oncogeni include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Oncogeni's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Oncogeni?

The key public trading comparables and valuation benchmarks for Oncogeni include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Oncogeni for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Oncogeni with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Oncogeni's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Oncogeni with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Oncogeni's' sector and industry vertical?

Access recent funding rounds and capital raises in Oncogeni's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Oncogeni